Author:
Oliver B.,Órpez T.,Mayorga C.,Pinto-Medel M.J.,Leyva L.,López-Gómez C.,Marín C.,Luque G.,Ortega-Pinazo J.,Fernández O.
Subject
Immunology,Immunology and Allergy
Reference25 articles.
1. A comparison of the biologic activity of two recombinant IFN-beta preparations used in the treatment of relapsing-remitting multiple sclerosis;Antonetti;J. Interferon Cytokine Res.,2002
2. Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients;Bertolotto;Neurology,2003
3. Bertolotto, A., Malucchi, S., Sala, A., Orefice, G., Carrieri, P.B., Capobianco, M., Milano, E., Melis, F., Giordana, M.T., 2002. Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory. J. Neurol. Neurosurg. Psychiatry 73 (2),148 Aug.
4. Interferon-beta response in multiple sclerosis associated with pre-treatment disability;Fernandez-Fernandez;Rev. Neurol.,2006
5. The expression of potency of neutralizing antibodies for interferons and other cytokines;Grossberg;Biotherapy,1997
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献